CVS Health Corp (CVS)
Working capital turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 372,809,000 | 357,776,000 | 322,467,000 | 292,111,000 | 268,706,000 |
| Total current assets | US$ in thousands | 68,645,000 | 67,858,000 | 65,633,000 | 60,008,000 | 56,369,000 |
| Total current liabilities | US$ in thousands | 84,609,000 | 79,189,000 | 69,421,000 | 67,807,000 | 62,017,000 |
| Working capital turnover | — | — | — | — | — |
December 31, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $372,809,000K ÷ ($68,645,000K – $84,609,000K)
= —
Based on the provided data, the working capital turnover for CVS Health Corp for the years 2020 through 2024 is not available as it is indicated by dashes (\u2014). Without specific numerical values for working capital turnover, we are unable to calculate or analyze this particular financial ratio for CVS Health Corp over the specified period.
Working capital turnover is a key financial ratio that measures a company's efficiency in utilizing its working capital to generate revenue. A higher working capital turnover ratio typically indicates that the company is effectively managing its working capital to generate sales.
In the absence of precise data for the working capital turnover ratio, it becomes challenging to assess CVS Health Corp's operational efficiency in utilizing its working capital during the specified period. It is recommended to obtain the necessary financial information to perform a more detailed analysis of CVS Health Corp's working capital turnover and its implications for the company's financial health and operational efficiency.
Peer comparison
Dec 31, 2024